C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2004
11/17/2004	CN1546472A Pyridyl alkane acid amides as cytostatics and immunosupressives
11/17/2004	CN1546470A 6-phenylpyridyl-2-amine derivatives
11/17/2004	CN1176074C Multi-substituted beta-monofluoropyrrole compounds and preparing process thereof
11/16/2004	US6818777 Intermediates for synthesis of vinblastine compound and method for synthesizing the intermediate
11/16/2004	US6818774 2-(s)-(6-(4-fluoro-benzyloxy)-3-oxo-3,4-dihydro-1h-isoquinolin -2-yl)- propionamide for example; alzheimer's disease or senile dementia
11/16/2004	US6818767 Neuropeptide y (npy) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity
11/16/2004	US6818655 2-aminoquinolines; cardiovascular, gastrointestinal, pyschological, respiratory and nervous system disorders
11/16/2004	US6818649 Chromenylmethyl pyrimidinediamines as antibacterial agents
11/16/2004	US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/11/2004	WO2004096798A2 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokine antagonists
11/11/2004	WO2004096795A2 C-fms kinase inhibitors
11/11/2004	WO2004096794A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs
11/11/2004	WO2004096793A1 New alicyclic-amine-substituted 4-carboxamido-benzimidazoles as parp-inhibitors and antioxidants
11/11/2004	WO2004096792A2 Novel indole derivatives, method of preparing same in the form of medicaments, pharmaceutical compositions and, in particular, kdr inhibitors
11/11/2004	WO2004096781A1 Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors o fteh enzyme myeloperoxidase (mpo)
11/11/2004	WO2004096777A1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
11/11/2004	WO2004096774A1 Acyl isoindoline derivatives and acyl isoquinoline derivatives as anti-viral agents
11/11/2004	WO2004096771A1 Biaryl compounds having activity at the 5ht5a receptor
11/11/2004	WO2004096768A1 Anti-diabetic agents
11/11/2004	WO2004096767A1 Sustituted indoline and indole derivatives
11/11/2004	WO2004096766A1 A method of indole synthesis
11/11/2004	WO2004096763A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
11/11/2004	WO2004096274A1 Drug for airway administration
11/11/2004	WO2004096213A1 Imidazolin-2-ylaminophenyl amides as ip antagonists
11/11/2004	WO2004096134A2 Substituted 1,4-diazepines and uses thereof
11/11/2004	WO2004096129A2 Inhibitors of akt activity
11/11/2004	WO2004087690A3 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
11/11/2004	WO2004085403B1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
11/11/2004	WO2004078875A3 Novel dyes and use thereof in imaging members and methods
11/11/2004	WO2004078748A3 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
11/11/2004	WO2004074244A3 Pyrimidine compounds
11/11/2004	WO2004072044A3 Urea and thiourea derivatives
11/11/2004	WO2004063152A3 Lansoprazole formulations and related processes and methods
11/11/2004	WO2004026844A9 Methods and compositions of novel triazine compounds
11/11/2004	WO2003079973A3 Mitotic kinesin inhibitors
11/11/2004	US20040225128 reacting paroxetine with isethionic acid; salt formation
11/11/2004	US20040225070 oxetane moiety is homopolymerizable; maleimide moiety is homo- or copolymerizable with electron donor compounds; dual curability; 6-maleimideocaproic acid-(3-alkyloxetan-3-yl) methyl ester
11/11/2004	US20040225005 substituted with p-chlorobenzene and a pyrrolethoxybenzene; antitumor
11/11/2004	US20040225000 4-(R'-Imino)-3-Mercapto-5-(R)4H-1,2,4-Triazols, 4-(R'-imino)-3-alkylthio-5-R-1,2,4-triazoles and 4-amino-3-mercapto-triazoles as inhibitors of nitric oxide synthase (NOS) and as inhibitors of malignant cell growth
11/11/2004	US20040224997 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/11/2004	US20040224993 Diphenylurea compounds
11/11/2004	US20040224990 Enantioselective hydrogenation of intermediates in the synthesis of tipranavir
11/11/2004	US20040224986 Piperidinyl targeting compounds that selectively bind integrins
11/11/2004	US20040224976 Azabicyclic compounds for the treatment of disease
11/11/2004	US20040224975 Nicotinamide derivatives useful as PDE4 inhibitors
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224960 Pharmaceutical compositions and methods for their use
11/11/2004	US20040224959 such as N-benzyl-3-[4-(3,3-diphenyl-1-propyl)piperazin-1-yl]-N-methylbenzamide; for inhibition of secretion of apolipoprotein B lipoprotein from the liver; for treatment of hyperlipidemia, pancreatitis
11/11/2004	US20040224955 Viral polymerase inhibitors
11/11/2004	US20040224953 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/11/2004	US20040224952 e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight.
11/11/2004	US20040224950 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/11/2004	US20040224944 Pyrazole compounds useful as protein kinase inhibitors
11/11/2004	US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
11/11/2004	US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement
11/11/2004	US20040223913 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo.
11/11/2004	US20040223912 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/11/2004	US20040223909 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/11/2004	CA2536964A1 C-fms kinase inhibitors
11/11/2004	CA2524251A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
11/11/2004	CA2523561A1 Substituted 1,4-diazepines and uses thereof
11/11/2004	CA2523426A1 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/11/2004	CA2523020A1 Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo)
11/11/2004	CA2522817A1 Imidazolin-2-ylaminophenyl amides as ip antagonists
11/11/2004	CA2522262A1 Inhibitors of akt activity
11/11/2004	CA2521962A1 Anti-diabetic agents
11/11/2004	CA2521158A1 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
11/11/2004	CA2520779A1 Agent for intra-airway administration
11/10/2004	EP1475371A1 1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/10/2004	EP1474421A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
11/10/2004	EP1474419A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
11/10/2004	EP1474400A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)] -6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
11/10/2004	EP1474399A1 Benzenesulfonamide derivatives as antipsychotic agents
11/10/2004	EP1474398A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of the same as pharmaceuticals
11/10/2004	EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004	EP1474149A2 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
11/10/2004	EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004	EP1474146A1 Phenylpyrimidine amines as ige inhibitors
11/10/2004	EP1474145A1 Quinoline derivatives as npy antagonists
11/10/2004	EP1474139A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/10/2004	CN1545700A Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
11/10/2004	CN1545512A Rapamycin dialdehydes
11/10/2004	CN1545511A Rapamycin 29-enols
11/10/2004	CN1545510A Quinazoline derivatives as alpha-1 adrenergic antagonists
11/10/2004	CN1545508A 1,2,4-trioxolane antimalarials
11/10/2004	CN1545502A Process for the preparation of indole derivatives
11/10/2004	CN1545411A Cyclopropyl and cyclobutyl epothilone analogs
11/10/2004	CN1174977C Pseudo polymorph of (-)-cis-2-(2-chlorophenyl)-5, 7-dihydroxy-8[4R-(3S-hydroxy-1-methyl) piperidinyl]-4H-1-benzopyran-4-one
11/10/2004	CN1174975C Benzopyrans compound and their use as therapeutic agent
11/09/2004	US6815548 Process for preparing a piperidine derivative
11/09/2004	US6815465 Heterocyclic compounds inhibiting angiogenesis
11/09/2004	US6815458 Nervous system disorders
11/09/2004	US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/09/2004	US6815440 For therapy and prophylaxis of disorders in the course of which is involved an increased activity of matrix-degrading metalloproteinases
11/04/2004	WO2004094412A1 Nk-2 antagonist basic linear compounds and formulations containing them
11/04/2004	WO2004094411A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors
11/04/2004	WO2004094404A1 4-imidazolin-2-one compounds
11/04/2004	WO2004094388A2 Indazole derivatives as jnk inhibitors
11/04/2004	WO2004094386A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b)

1 ... 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 ... 694